Fig. 1. FAM83H over-expression is associated with poor prognosis of CC

Slides:



Advertisements
Similar presentations
G Mustacchi 1, F Zanconati 2, D Bonifacio 2, L Morandi 3, MP Sormani 4, A. Gennari 5, P Bruzzi 4 1: Centro Oncolgico University of Trieste 2: Inst of Pathology,
Advertisements

Down-regulated expression of family with sequence similarity 3, member B (FAM3B), in oral squamous cell carcinoma  Masashi Shiiba, Shunsaku Ishige, Yasuhiro.
Volume 67, Issue 1, Pages (January 2015)
Lung squamous cell carcinoma
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
TBCRC (the translational breast cancer research consortium) 005 Prospective study
Potential Molecular Mechanisms for Improved Prognosis and Outcome with Neoadjuvant Chemotherapy Prior to Laparoscopical Radical Hysterectomy for Patients.
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment Liver.
Volume 15, Pages (February 2017)
Figure 3. Sensitivity of the gastric carcinoma cell line N87 for trastuzumab in comparison with the breast cancer cell line SKBR-3. (A) Dose–response curves.
Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.
Cell Physiol Biochem 2016;40: DOI: /
Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma  Kuang-Tzu Huang, I-Ying Kuo, Ming-Chao.
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 149, Issue 2, Pages (May 2018)
Strategy Description Discovery Validation Application
Nat. Rev. Urol. doi: /nrurol
Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non–Small Cell Lung Cancer Patients 
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Snail Enhances Glycolysis in the Epithelial-Mesenchymal Transition Process by Targeting FBP1 in Gastric Cancer Cell Physiol Biochem 2017;43:31–38 - DOI: /
Volume 67, Issue 1, Pages (January 2015)
Kenneth G. Geles, Wenyan Zhong, Siobhan K
AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma  Daniel L. Albertus, BS, Christopher.
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Long Interspersed Nucleotide Element 1 Hypomethylation Is Associated With Poor Prognosis of Lung Adenocarcinoma  Koei Ikeda, MD, PhD, Kenji Shiraishi,
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
Volume 44, Issue 5, Pages (November 2003)
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer  Mark N. Adams, PhD, Joshua T. Burgess, PhD,
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Molecular Therapy - Nucleic Acids
Somatic promoters correlate with immunoediting signatures.
Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis 
Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer  Akihito Watanabe, MD, Masao Hosokawa, MD,
Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.
Molecular Therapy - Nucleic Acids
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis  Xin Luo, MD, Xiao Zang, BS, Lin Yang, MD, Junzhou Huang, PhD,
Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma  Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,
Fig. 1. miR-370 was downregulated, and GUCD1 was upregulated in HCC
A Novel Approach to Detect Programed Death Ligand 1 (PD-L1) Status and Multiple Tumor Mutations Using a Single Non–Small-Cell Lung Cancer (NSCLC) Bronchoscopy.
Christina I. Selinger, PhD, Wendy A
mRNA level as % relative to
miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
MiR-205 and MiR-375 MicroRNA Assays to Distinguish Squamous Cell Carcinoma from Adenocarcinoma in Lung Cancer Biopsies  Santosh Patnaik, MD, PhD, Reema.
Volume 5, Issue 3, Pages (November 2013)
Fold Change of hsa-miR-3687 (T/N)(log2)
MicroRNA-381 Represses ID1 and is Deregulated in Lung Adenocarcinoma
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
A Strategy for Determining Which Thoracic Esophageal Cancer Patients Should Undergo Cervical Lymph Node Dissection  Shiro Nagatani, MD, Yutaka Shimada,
DNMT3A1 signatures are not recapitulated in AML.
DNMT3A2 signatures are coherently modified in AML.
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Transcriptome Sequencing Demonstrates that Human Papillomavirus Is Not Active in Cutaneous Squamous Cell Carcinoma  Sarah T. Arron, J. Graham Ruby, Eric.
Fig. 1. Kaplan-Meier curves for PFS and OS
Figure S1. A. B. Figure S1. Kaplan-Meier curve of progression-free survival by treatment group in soluble heregulin (HRG)-high population (A) and soluble.
Figure 1. Identification of differentially expressed messenger RNAs (mRNAs) in the The Cancer Genome Atlas (TCGA) BRCA database. (A) Heat map of the log2-fold.
TERT promoter mutations and telomerase reactivation in urothelial cancer by Sumit Borah, Linghe Xi, Arthur J. Zaug, Natasha M. Powell, Garrett M. Dancik,
Supplementary Figure S1
Reduced BAI1 expression is associated with breast cancer patient survival. Reduced BAI1 expression is associated with breast cancer patient survival. A,
MAPJD expression in lung cancers.
Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.
Efficacy of nivolumab in Japanese patients with advanced non-squamous non-small cell lung cancer (A) Kaplan-Meier curve for PFS, (B) Kaplan-Meier curve.
Ki-67 expression is determined by the cell-cycle stage.
Expression pattern of TLR-4 and MyD88 in EOC cells.
Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell.
Reduced klotho expression in pancreatic cancer.
lncRNA HOXA11-AS is overexpressed in gastric cancer tissues.
Superenhancers near the KLF5 gene are focally amplified in diverse cancer types. Superenhancers near the KLF5 gene are focally amplified in diverse cancer.
Volume 28, Issue 4, Pages e6 (July 2019)
Overexpression of SUFU and GLI1 in the poor clinical outcome subgroup was confirmed by real-time PCR along with its association with disease progression.
Presentation transcript:

Fig. 1. FAM83H over-expression is associated with poor prognosis of CC Fig. 1. FAM83H over-expression is associated with poor prognosis of CC. (A) FAM83H expression at mRNA level in CC tissues in TCGA database. (B) FAM83H expression at mRNA level in CC tissues in GEPIA database (match TCGA normal data). (C) FAM83H expression at mRNA level in CC tissues in GEPIA database (match TCGA normal and GTEx data). (D) Real-time Quantitative Reverse Transcription PCR used to measure the expression level of FAM83H in human CC cell lines (SiHa and HeLa). The expression of FAM83H was significantly higher in CC cells relative to control cells. (E) Kaplan-Meier curves of OS of CC patients in TCGA database. Patients were sub-grouped into high (n=152) or low (n=152) groups based on the median of FAM83H expression. p=0.027. (F) Kaplan-Meier curves of OS of CC patients in GEPIA database. Patients were sub-grouped into high (n=146) or low (n=146) groups based on the median of FAM83H expression. (G) Kaplan-Meier curves of OS of CC patients in the Human Protein Atlas database. Patients were sub-grouped into high (n=224) or low (n=67) groups based on best cut-off point (p=0.004). *p<0.05, **p<0.01. FAM83H, family with sequence similarity 83 member H; CC, cervical cancer; TCGA, The Cancer Genome Atlas; GEPIA, Gene Expression Profiling Interactive Analysis; OS, overall survival; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; TPM, transcripts per million; HR, hazard ratio. Fig. 1. FAM83H over-expression is associated with poor prognosis of CC. (A) FAM83H expression at mRNA level in CC tissues in TCGA database. (B) FAM83H expression at mRNA level in CC tissues in GEPIA database (match TCGA normal data). (C) FAM83H expression at mRNA… Yonsei Med J. 2019 Jul;60(7):611-618. https://doi.org/10.3349/ymj.2019.60.7.611